Treatment of allergic reactions
Pro Research Analysisby 
Searched over 200M research papers
Pharmacological Treatments for Allergic Reactions
Pharmacological management of allergic reactions commonly involves antihistamines, corticosteroids, and, in some cases, monoclonal antibodies. Second-generation H1-antihistamines are considered the first-line treatment for most allergic diseases due to their rapid action and minimal side effects, especially compared to first-generation antihistamines, which can cause sedation and cognitive impairment . Corticosteroids are also widely used, particularly for acute allergic reactions, and new formulations such as oral films that dissolve on the tongue offer faster and more convenient administration, which is preferred by patients and may improve adherence . Monoclonal antibodies are increasingly used for severe or refractory allergic diseases, but their use requires careful monitoring due to the risk of adverse drug reactions . Additionally, ongoing research into synthetic anti-allergy small molecules targets various pathways, including histamine receptors, leukotriene biosynthesis, Th2 cytokines, and calcium channels, aiming to improve efficacy and reduce side effects .
Allergen Immunotherapy (AIT) and Disease Modification
Allergen immunotherapy (AIT) is the only treatment that can modify the course of allergic diseases such as allergic rhinitis and asthma, rather than just controlling symptoms 145. AIT works by gradually exposing patients to increasing doses of allergens, either through subcutaneous injections or sublingual drops/tablets, over several years. This approach can induce long-term tolerance, reduce symptoms, and decrease the need for medication even after treatment ends 145. The mechanisms behind AIT include changes in immunoglobulin levels, induction of regulatory T cells, shifts in cytokine profiles, and suppression of inflammatory cell activity 145. However, AIT requires prolonged treatment and carries a risk of adverse reactions, especially in patients with severe allergies 46.
Advances in Immunotherapy: Peptide-Based and Molecular Approaches
Recent advances in immunotherapy include the development of peptide immunotherapy (PIT), which uses T cell epitope peptides to induce immune tolerance with fewer side effects than traditional AIT 36. PIT has shown promising results in clinical trials for various allergens, demonstrating safety, efficacy, and good tolerability . Molecular AIT, which uses modified allergens or recombinant proteins, aims to improve safety and efficacy by reducing IgE reactivity and targeting specific immune pathways 56. These novel approaches may shorten treatment duration and further reduce the risk of adverse reactions 56.
Targeted Therapies and Future Directions
Targeted therapies, such as crystal-dissolving antibodies against Charcot-Leyden crystals, represent a new frontier in treating severe allergic diseases like asthma and chronic rhinosinusitis. These therapies directly address the underlying immune mechanisms that drive allergic inflammation and have shown potential to reverse disease symptoms . Continued research into the molecular and cellular mechanisms of allergy is expected to yield more precise and effective treatments, including custom-tailored therapies based on individual disease profiles and biomarkers 45.
Conclusion
The treatment of allergic reactions has evolved from symptom control with antihistamines and corticosteroids to disease-modifying strategies like allergen immunotherapy and targeted biologics. Second-generation antihistamines and new corticosteroid formulations offer effective and patient-friendly options for acute management, while advances in immunotherapy and molecular medicine promise safer, more durable solutions for long-term control and potential cure of allergic diseases. Ongoing research and innovation continue to improve outcomes and quality of life for individuals with allergies.
Sources and full results
Most relevant research papers on this topic